Healthcare provider profile · identity verified

Ronda Keller

Internal Medicine · CLACKAMAS, OR · NPI 1477573889

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	495	139
Amlodipine Besylate	Amlodipine Besylate	423	129
Losartan Potassium	Losartan Potassium	420	125
Lisinopril	Lisinopril	351	106
Levothyroxine Sodium	Levothyroxine Sodium	317	88
Metoprolol Succinate	Metoprolol Succinate	313	95
Pantoprazole Sodium	Pantoprazole Sodium	245	88
Trazodone Hcl	Trazodone Hcl	238	78
Pravastatin Sodium	Pravastatin Sodium	215	59
Gabapentin	Gabapentin	213	75
Metformin Hcl Er	Metformin Hcl	201	72
Rosuvastatin Calcium	Rosuvastatin Calcium	201	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	199	34
Simvastatin	Simvastatin	187	53
Escitalopram Oxalate	Escitalopram Oxalate	184	55
Albuterol Sulfate Hfa	Albuterol Sulfate	174	64
Potassium Chloride	Potassium Chloride	164	51
Pregabalin	Pregabalin	154	56
Pradaxa	Dabigatran Etexilate Mesylate	144	47
Fluoxetine Hcl	Fluoxetine Hcl	118	38
Furosemide	Furosemide	111	36
Metoprolol Tartrate	Metoprolol Tartrate	105	34
Oxycodone Hcl	Oxycodone Hcl	105	25
Duloxetine Hcl	Duloxetine Hcl	103	30
Meloxicam	Meloxicam	103	40
Omeprazole	Omeprazole	100	24
Alvesco	Ciclesonide	97	44
Sertraline Hcl	Sertraline Hcl	94	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	93	14
Glipizide	Glipizide	91	28
Citalopram Hbr	Citalopram Hydrobromide	85	22
Estradiol	Estradiol	85	49
Mirtazapine	Mirtazapine	84	20
Alendronate Sodium	Alendronate Sodium	82	32
Metformin Hcl	Metformin Hcl	82	25
Jardiance	Empagliflozin	81	31
Chlorthalidone	Chlorthalidone	78	26
Humulin N	Insulin Nph Human Isophane	78	23
Hydrochlorothiazide	Hydrochlorothiazide	77	25
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	77	17
Spironolactone	Spironolactone	70	24
Atenolol	Atenolol	68	17
Venlafaxine Hcl Er	Venlafaxine Hcl	67	19
Tamsulosin Hcl	Tamsulosin Hcl	65	21
Allopurinol	Allopurinol	60	19
Triamcinolone Acetonide	Triamcinolone Acetonide	59	35
Clopidogrel	Clopidogrel Bisulfate	58	16
Arexvy	Rsvpref3 Antigen/As01e/Pf	57	57
Carvedilol	Carvedilol	57	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	14
Quetiapine Fumarate	Quetiapine Fumarate	54	13
Wixela Inhub	Fluticasone Propion/Salmeterol	54	23
Ondansetron Odt	Ondansetron	53	30
Ozempic	Semaglutide	53	suppressed
Eliquis	Apixaban	52	13
Prednisone	Prednisone	52	40
Torsemide	Torsemide	51	18
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	51	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	16
Montelukast Sodium	Montelukast Sodium	48	16
Bupropion Hcl Sr	Bupropion Hcl	45	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	20
Warfarin Sodium	Warfarin Sodium	45	14
Nystatin	Nystatin	41	21
Bupropion Xl	Bupropion Hcl	37	12
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	37	12
Buspirone Hcl	Buspirone Hcl	36	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	36	11
Tramadol Hcl	Tramadol Hcl	36	11
Ketoconazole	Ketoconazole	35	11
Morphine Sulfate Er	Morphine Sulfate	35	suppressed
Terazosin Hcl	Terazosin Hcl	35	11
Celecoxib	Celecoxib	33	12
Etodolac	Etodolac	33	11
Naltrexone Hcl	Naltrexone Hcl	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	suppressed
Ibuprofen	Ibuprofen	31	13
Humulin R	Insulin Regular, Human	29	12
Trospium Chloride	Trospium Chloride	29	13
Famotidine	Famotidine	27	11
Acyclovir	Acyclovir	26	suppressed
Spiriva Respimat	Tiotropium Bromide	26	12
Lovastatin	Lovastatin	25	suppressed
Divalproex Sodium	Divalproex Sodium	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	24	12
Baclofen	Baclofen	23	suppressed
Rizatriptan	Rizatriptan Benzoate	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Topiramate	Topiramate	23	13
Valacyclovir	Valacyclovir Hcl	23	suppressed
Nitroglycerin	Nitroglycerin	22	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	22	22
Colchicine	Colchicine	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Hydrocortisone	Hydrocortisone	20	13
Hydromorphone Hcl	Hydromorphone Hcl	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Epinephrine	Epinephrine	18	11
Irbesartan	Irbesartan	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Primidone	Primidone	18	suppressed
Cefadroxil	Cefadroxil	17	11
Doxepin Hcl	Doxepin Hcl	17	suppressed
Liraglutide	Liraglutide	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Finasteride	Finasteride	16	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Sucralfate	Sucralfate	15	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	15	15
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Prazosin Hcl	Prazosin Hcl	12	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	12	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	11
Ezetimibe	Ezetimibe	11	suppressed
Fluoridex	Fluoride (Sodium)	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Tacrolimus	Tacrolimus	11	suppressed
Veo Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error